These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
77 related articles for article (PubMed ID: 22749870)
1. Discovery of benzylisothioureas as potent divalent metal transporter 1 (DMT1) inhibitors. Zhang Z; Kodumuru V; Sviridov S; Liu S; Chafeev M; Chowdhury S; Chakka N; Sun J; Gauthier SJ; Mattice M; Ratkay LG; Kwan R; Thompson J; Cutts AB; Fu J; Kamboj R; Goldberg YP; Cadieux JA Bioorg Med Chem Lett; 2012 Aug; 22(15):5108-13. PubMed ID: 22749870 [TBL] [Abstract][Full Text] [Related]
2. Synthesis and biological evaluation of substituted pyrazoles as blockers of divalent metal transporter 1 (DMT1). Cadieux JA; Zhang Z; Mattice M; Brownlie-Cutts A; Fu J; Ratkay LG; Kwan R; Thompson J; Sanghara J; Zhong J; Goldberg YP Bioorg Med Chem Lett; 2012 Jan; 22(1):90-5. PubMed ID: 22154351 [TBL] [Abstract][Full Text] [Related]
3. Transport of divalent transition-metal ions is lost in small-intestinal tissue of b/b Belgrade rats. Knöpfel M; Zhao L; Garrick MD Biochemistry; 2005 Mar; 44(9):3454-65. PubMed ID: 15736955 [TBL] [Abstract][Full Text] [Related]
4. Intestinal DMT1 cotransporter is down-regulated by hepcidin via proteasome internalization and degradation. Brasse-Lagnel C; Karim Z; Letteron P; Bekri S; Bado A; Beaumont C Gastroenterology; 2011 Apr; 140(4):1261-1271.e1. PubMed ID: 21199652 [TBL] [Abstract][Full Text] [Related]
5. Discovery and characterization of a novel non-competitive inhibitor of the divalent metal transporter DMT1/SLC11A2. Montalbetti N; Simonin A; Simonin C; Awale M; Reymond JL; Hediger MA Biochem Pharmacol; 2015 Aug; 96(3):216-24. PubMed ID: 26047847 [TBL] [Abstract][Full Text] [Related]
6. ZIP14 and DMT1 in the liver, pancreas, and heart are differentially regulated by iron deficiency and overload: implications for tissue iron uptake in iron-related disorders. Nam H; Wang CY; Zhang L; Zhang W; Hojyo S; Fukada T; Knutson MD Haematologica; 2013 Jul; 98(7):1049-57. PubMed ID: 23349308 [TBL] [Abstract][Full Text] [Related]
7. The transcytosis of divalent metal transporter 1 and apo-transferrin during iron uptake in intestinal epithelium. Ma Y; Specian RD; Yeh KY; Yeh M; Rodriguez-Paris J; Glass J Am J Physiol Gastrointest Liver Physiol; 2002 Oct; 283(4):G965-74. PubMed ID: 12223357 [TBL] [Abstract][Full Text] [Related]
8. Regulation of divalent metal transporter expression in human intestinal epithelial cells following exposure to non-haem iron. Johnson DM; Yamaji S; Tennant J; Srai SK; Sharp PA FEBS Lett; 2005 Mar; 579(9):1923-9. PubMed ID: 15792797 [TBL] [Abstract][Full Text] [Related]
9. Up-regulation of divalent metal transporter 1 in 6-hydroxydopamine intoxication is IRE/IRP dependent. Jiang H; Song N; Xu H; Zhang S; Wang J; Xie J Cell Res; 2010 Mar; 20(3):345-56. PubMed ID: 20125122 [TBL] [Abstract][Full Text] [Related]
10. Potent, Gut-Restricted Inhibitors of Divalent Metal Transporter 1: Preclinical Efficacy against Iron Overload and Safety Evaluation. Cutts A; Chowdhury S; Ratkay LG; Eyers M; Young C; Namdari R; Cadieux JA; Chahal N; Grimwood M; Zhang Z; Lin S; Tietjen I; Xie Z; Robinette L; Sojo L; Waldbrook M; Hayden M; Mansour T; Pimstone S; Goldberg YP; Webb M; Cohen CJ J Pharmacol Exp Ther; 2023 Jul; 386(1):4-14. PubMed ID: 36958846 [TBL] [Abstract][Full Text] [Related]
11. Small-molecule screening identifies the selanazal drug ebselen as a potent inhibitor of DMT1-mediated iron uptake. Wetli HA; Buckett PD; Wessling-Resnick M Chem Biol; 2006 Sep; 13(9):965-72. PubMed ID: 16984886 [TBL] [Abstract][Full Text] [Related]
12. Participation of divalent cation transporter DMT1 in the uptake of inorganic mercury. Vázquez M; Vélez D; Devesa V; Puig S Toxicology; 2015 May; 331():119-24. PubMed ID: 25772431 [TBL] [Abstract][Full Text] [Related]
13. Not all DMT1 mutations lead to iron overload. Blanco E; Kannengiesser C; Grandchamp B; Tasso M; Beaumont C Blood Cells Mol Dis; 2009; 43(2):199-201. PubMed ID: 19553145 [TBL] [Abstract][Full Text] [Related]
14. Ontogenic changes in lactoferrin receptor and DMT1 in mouse small intestine: implications for iron absorption during early life. Lopez V; Suzuki YA; Lönnerdal B Biochem Cell Biol; 2006 Jun; 84(3):337-44. PubMed ID: 16936804 [TBL] [Abstract][Full Text] [Related]
15. Previously uncharacterized isoforms of divalent metal transporter (DMT)-1: implications for regulation and cellular function. Hubert N; Hentze MW Proc Natl Acad Sci U S A; 2002 Sep; 99(19):12345-50. PubMed ID: 12209011 [TBL] [Abstract][Full Text] [Related]
16. Iron, copper, and zinc transport: inhibition of divalent metal transporter 1 (DMT1) and human copper transporter 1 (hCTR1) by shRNA. Espinoza A; Le Blanc S; Olivares M; Pizarro F; Ruz M; Arredondo M Biol Trace Elem Res; 2012 May; 146(2):281-6. PubMed ID: 22068728 [TBL] [Abstract][Full Text] [Related]
17. Iron Imports. V. Transport of iron through the intestinal epithelium. Ma Y; Yeh M; Yeh KY; Glass J Am J Physiol Gastrointest Liver Physiol; 2006 Mar; 290(3):G417-22. PubMed ID: 16474007 [TBL] [Abstract][Full Text] [Related]
18. A novel R416C mutation in human DMT1 (SLC11A2) displays pleiotropic effects on function and causes microcytic anemia and hepatic iron overload. Lam-Yuk-Tseung S; Camaschella C; Iolascon A; Gros P Blood Cells Mol Dis; 2006; 36(3):347-54. PubMed ID: 16584902 [TBL] [Abstract][Full Text] [Related]
19. Small molecule inhibitors of divalent metal transporter-1. Buckett PD; Wessling-Resnick M Am J Physiol Gastrointest Liver Physiol; 2009 Apr; 296(4):G798-804. PubMed ID: 19179627 [TBL] [Abstract][Full Text] [Related]
20. Two routes of iron accumulation in astrocytes: ascorbate-dependent ferrous iron uptake via the divalent metal transporter (DMT1) plus an independent route for ferric iron. Lane DJ; Robinson SR; Czerwinska H; Bishop GM; Lawen A Biochem J; 2010 Nov; 432(1):123-32. PubMed ID: 20819077 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]